Revolution in diabetes supply: New CGM system from Sinocare is coming!

Revolution in diabetes supply: New CGM system from Sinocare is coming!

The healthcare industry is experiencing a groundbreaking progress! A. Menarini Diagnostics has announced an exclusive sales agreement with Sinocare in an exciting development in order to register and market an innovative system for continuous glucose monitoring (CGM) of the third generation in more than 20 European countries. This partnership opens up new perspectives for diabetes supply and enables precise and continuous blood sugar measurement, which is of crucial importance for patients. Dr. Jiangfeng Feu, head of the CGM Business Unit of Sinocare, was enthusiastic about the collaboration and emphasized that this was an important step to make the advanced systems popular, as is also reported on the Sinocare website.

a. Menarini Diagnostics emphasizes that the agreement is in accordance with its aim to provide innovative solutions for health care. Fabio Piazzalunga, the General Manager, explained that they are optimistic to serve the growing demand for modern diabetes supply solutions. With its comprehensive network and its specialized resources, the company wants to ensure that the advanced CGM systems from Sinocare reach patients who can benefit the most from these technologies.

Sinocare’s strong influence

Sinocare, as the largest manufacturer of blood sugar measuring devices in Asia, looks back on 20 years of experience in the industry and has established itself globally through the acquisitions of NIPRO DIAGNOSTIC Inc. and PTS Diagnostics Inc. The company recently confirmed its commitment to the development of biosensor technologies and strives to improve the quality of life of people with diabetes and other chronic diseases through high-quality products and services. Sinocare, which has also been recognized for its national innovation projects, is often celebrated as a leading provider in blood glucose monitoring, as can be seen on the Sinocare website

Through this important partnership, both A. Menarini Diagnostics and Sinocare expect a significant expansion of the availability of their highly developed technologies and the fulfillment of the growing needs of diabetes patients in Europe.